Overview

Drug Discovery Market is estimated to value over USD 19 billion by 2027 end with a CAGR of over 12% during the forecast period 2020 to 2027.

The increasing occurrence of chronic diseases like central nervous system-related conditions, cardiovascular diseases, soaring healthcare expenditure, pending expiration of drug-related patents are some of the major factors responsible for the growth of the market. There has been a rise in the implementation of novel technologies like bioinformatics, combinational chemistry and high throughput for identifying drug candidates efficiently. This has evolved drug discovery sector, thereby helping in refining the process which consumes less time and provides accurate results. The automation has evolved technologies like imaging software and hardware, multi-detector readers and high-throughput screening for discovering drugs. Recently, there has been a surging insistence for speciality medicines which has boosted the drug discovery market growth. The biologic drugs are utilised for treating multiple conditions and diseases and these are novel technologies. These drugs are used for treating autoimmune diseases like psoriasis, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, etc. Such a wide range of applications shall increase the drug discovery market demand. 

Drug Discovery Market

Market Segmentation:

By Process
•    Target Selection
•    target Validation
•    Hit-To-Lead Identification
•    Lead Optimization
•    Candidate Validation
By Type
•    Medicinal Chemistry Services
•    Biology Services
•    Drug Metabolism and Pharmacokinetics
By Drug
•    Small Molecule Drugs
•    Biologic Drugs
By Therapeutic Area
•    Oncology
•    Central Nervous Systems
•    Cardiovascular
•    Infectious Disease
•    Metabolic Disorders
•    Others    
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into process, type, drug, therapeutic area and region. The process segment is fragmented into target selection, target validation, hit-to-lead identification, lead optimization and candidate validation. The type segment is bifurcated into medicinal chemistry services, biology services, drug metabolism and pharmacokinetics. The medicinal chemistry segment is predicted to hold the largest drug discovery market share, and this can be credited to the wide range of applications of medicinal chemistry for drug discovery in delivering robust candidates. The drug segment is categorised into small molecule drugs and biologic drugs. The biologic drugs segment is predicted to dominate the market as it used for treating a variety of autoimmune diseases. The therapeutic area segment is bifurcated into oncology, neurology, infectious and immune system diseases, digestive system diseases, cardiovascular diseases and other therapeutic areas. The oncology segment is predicted to lead the market owing to the rising prevalence of various cancer types, increased insistence for efficient cancer-related therapies and the rising expenditure on research and development by pharma companies. 

Regional Analysis:

The Asia Pacific region is expected to dominate the market owing to technological advancements and increasing patient population which encourages research in drug discovery and development. Rising number of Contract Resource Organizations and a strong presence of key market players in the region.

Competitive Landscape:                            

The key market players are Laboratory Corporation of America Holdings, Albany Molecular Research Inc., Charles River Laboratories International Inc., Evotec SE, Eurofins Scientific, WuXi AppTec, GenScript Biotech Corporation, Thermo Fisher Scientific Inc., Pharmaceutical Product Development LLC, Syngene International Ltd., Selvita S.A.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global drug discovery market by process, by type, by drug, by therapeutic area and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics